Capillary-leak syndrome: an unrecognized early immune adverse effect of checkpoint-inhibitors treatment.
Immunotherapy. 2021 Apr 13. doi: 10.2217/imt-2020-0332. Online ahead of print.
Immunotherapy. 2021.
PMID: 33847145